263 related articles for article (PubMed ID: 14746860)
21. Treatment outcomes and prognostic factors in children with hepatoblastoma using a risk-stratified approach.
Srinivasan S; Prasad M; Parambil BC; Shrimal A; Gollamudi VRM; Subramani V; Ramadwar M; Khanna N; Baheti AD; Gala K; Patil V; Laskar S; Qureshi S; Chinnaswamy G
Pediatr Blood Cancer; 2023 Jul; 70(7):e30302. PubMed ID: 37046413
[TBL] [Abstract][Full Text] [Related]
22. Increased efficacy of CDDP in a xenograft model of hepatoblastoma using the apoptosis sensitizer ABT-737.
Lieber J; Dewerth A; Wenz J; Kirchner B; Eicher C; Warmann SW; Fuchs J; Armeanu-Ebinger S
Oncol Rep; 2013 Feb; 29(2):646-52. PubMed ID: 23229825
[TBL] [Abstract][Full Text] [Related]
23. Long-term morbidity and mortality in 2-year hepatoblastoma survivors treated with SIOPEL risk-adapted strategies.
Illiano M; Colinard M; Taque S; Mallon B; Larue C; Laithier V; Vérité-Goulard C; Sudour-Bonnange H; Faure-Conter C; Coze C; Aerts I; De Maricourt CD; Paillard C; Branchereau S; Brugières L; Fresneau B
Hepatol Int; 2022 Feb; 16(1):125-134. PubMed ID: 34506008
[TBL] [Abstract][Full Text] [Related]
24. Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma.
Perilongo G; Maibach R; Shafford E; Brugieres L; Brock P; Morland B; de Camargo B; Zsiros J; Roebuck D; Zimmermann A; Aronson D; Childs M; Widing E; Laithier V; Plaschkes J; Pritchard J; Scopinaro M; MacKinlay G; Czauderna P
N Engl J Med; 2009 Oct; 361(17):1662-70. PubMed ID: 19846851
[TBL] [Abstract][Full Text] [Related]
25. Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma.
Malogolowkin MH; Katzenstein H; Krailo MD; Chen Z; Bowman L; Reynolds M; Finegold M; Greffe B; Rowland J; Newman K; Womer RB; London WB; Castleberry RP
J Clin Oncol; 2006 Jun; 24(18):2879-84. PubMed ID: 16782927
[TBL] [Abstract][Full Text] [Related]
26. Resectability and tumor response after preoperative chemotherapy in hepatoblastoma treated by the Japanese Study Group for Pediatric Liver Tumor (JPLT)-2 protocol.
Hiyama E; Hishiki T; Watanabe K; Ida K; Yano M; Oue T; Iehara T; Hoshino K; Koh K; Tanaka Y; Kurihara S; Ueda Y; Onitake Y
J Pediatr Surg; 2016 Dec; 51(12):2053-2057. PubMed ID: 27712887
[TBL] [Abstract][Full Text] [Related]
27. Carboplatin and doxorubicin (CARDOX) for nonmetastatic hepatoblastoma: a discouraging pilot study.
Dall'Igna P; Cecchetto G; Dominici C; Donfrancesco A; Carli M; Indolfi P; Guglielmi M; Perilongo G
Med Pediatr Oncol; 2001 Feb; 36(2):332-4. PubMed ID: 11452948
[No Abstract] [Full Text] [Related]
28. Tumor rupture in hepatoblastoma: A high risk factor?
Pondrom M; Pariente D; Mallon B; Taque S; Branchereau S; Chardot C; Laithier V; Tabone MD; Lejeune J; Faure-Conter C; Saumet L; Vérité C; Aerts I; Brugières L; Fresneau B
Pediatr Blood Cancer; 2020 Sep; 67(9):e28549. PubMed ID: 32618436
[TBL] [Abstract][Full Text] [Related]
29. Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group.
O'Neill AF; Towbin AJ; Krailo MD; Xia C; Gao Y; McCarville MB; Meyers RL; McGahren ED; Tiao GM; Dunn SP; Langham MR; Weldon CB; Finegold MJ; Ranganathan S; Furman WL; Malogolowkin M; Rodriguez-Galindo C; Katzenstein HM
J Clin Oncol; 2017 Oct; 35(30):3465-3473. PubMed ID: 28892430
[TBL] [Abstract][Full Text] [Related]
30. Etoposide, cisplatin, epirubicin chemotherapy in the treatment of pediatric liver tumors.
Casanova M; Massimino M; Ferrari A; Spreafico F; Piva L; Coppa J; Luksch R; Cefalo G; Terenziani M; Polastri D; Bellani FF; Mazzaferro V
Pediatr Hematol Oncol; 2005; 22(3):189-98. PubMed ID: 16020101
[TBL] [Abstract][Full Text] [Related]
31. The influence of preoperative chemotherapy and surgical technique in the treatment of hepatoblastoma--a report from the German Cooperative Liver Tumour Studies HB 89 and HB 94.
Fuchs J; Rydzynski J; Hecker H; Mildenberger H; Bürger D; Harms D; V Schweinitz D;
Eur J Pediatr Surg; 2002 Aug; 12(4):255-61. PubMed ID: 12369004
[TBL] [Abstract][Full Text] [Related]
32. Redefining the role of doxorubicin for the treatment of children with hepatoblastoma.
Malogolowkin MH; Katzenstein HM; Krailo M; Chen Z; Quinn JJ; Reynolds M; Ortega JA
J Clin Oncol; 2008 May; 26(14):2379-83. PubMed ID: 18467729
[TBL] [Abstract][Full Text] [Related]
33. Single-agent cisplatin treatment of children with high-risk hepatoblastoma.
Zhang YT; Feng LH; Zhong XD; Wang LZ; Chang J
J Pediatr Hematol Oncol; 2014 May; 36(4):271-5. PubMed ID: 24309602
[TBL] [Abstract][Full Text] [Related]
34. Survival and long-term outcomes in children with hepatoblastoma treated with continuous infusion of cisplatin and doxorubicin.
Sivaprakasam P; Gupta AA; Greenberg ML; Capra M; Nathan PC
J Pediatr Hematol Oncol; 2011 Aug; 33(6):e226-30. PubMed ID: 21792028
[TBL] [Abstract][Full Text] [Related]
35. A trend of improved survival of childhood hepatoblastoma treated with cisplatin and doxorubicin in Taiwanese children.
Chiu SN; Ni YH; Lu MY; Lin DT; Lin KH; Lai HS; Chang MH
Pediatr Surg Int; 2003 Oct; 19(8):593-7. PubMed ID: 14556026
[TBL] [Abstract][Full Text] [Related]
36. Treatment-related acute myelomonocytic leukemia with t(11;19) in a child following chemotherapy for hepatoblastoma.
Koga Y; Matsuzaki A; Suminoe A; Washitoh N; Hara T; Hara T; Tajiri T; Taguchi T
Pediatr Blood Cancer; 2008 Apr; 50(4):943-4. PubMed ID: 17973320
[No Abstract] [Full Text] [Related]
37. Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma--results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience.
Weeda VB; Murawski M; McCabe AJ; Maibach R; Brugières L; Roebuck D; Fabre M; Zimmermann A; Otte JB; Sullivan M; Perilongo G; Childs M; Brock P; Zsíros J; Plaschkes J; Czauderna P; Aronson DC
Eur J Cancer; 2013 Aug; 49(12):2698-704. PubMed ID: 23683550
[TBL] [Abstract][Full Text] [Related]
38. Improved long-term survival with preoperative chemotherapy for hepatoblastoma.
Ehrlich PF; Greenberg ML; Filler RM
J Pediatr Surg; 1997 Jul; 32(7):999-1002; discussion 1002-3. PubMed ID: 9247221
[TBL] [Abstract][Full Text] [Related]
39. Hepatoblastoma--evolution of management and outcome and significance of histology of the resected tumor. A 31-year experience with 40 cases.
Davies JQ; de la Hall PM; Kaschula RO; Sinclair-Smith CC; Hartley P; Rode H; Millar AJ
J Pediatr Surg; 2004 Sep; 39(9):1321-7. PubMed ID: 15359384
[TBL] [Abstract][Full Text] [Related]
40. Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss.
Brock PR; Maibach R; Childs M; Rajput K; Roebuck D; Sullivan MJ; Laithier V; Ronghe M; Dall'Igna P; Hiyama E; Brichard B; Skeen J; Mateos ME; Capra M; Rangaswami AA; Ansari M; Rechnitzer C; Veal GJ; Covezzoli A; Brugières L; Perilongo G; Czauderna P; Morland B; Neuwelt EA
N Engl J Med; 2018 Jun; 378(25):2376-2385. PubMed ID: 29924955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
